InChI=1S/C27H29NO11/c1-10-22(31)13(28)6-17(38-10)39-15-8-27(36,16(30)9-29)7-12-19(15)26(35)21-20(24(12)33)23(32)11-4-3-5-14(37-2)18(11)25(21)34/h3-5,10,13,15,17,22,29,31,33,35-36H,6-9,28H2,1-2H3/t10-,13-,15-,17-,22+,27-/m0/s1 |
AOJJSUZBOXZQNB-TZSSRYMLSA-N |
COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](O[C@H]5C[C@H](N)[C@H](O)[C@H](C)O5)c4c(O)c3C(=O)c12)C(=O)CO |
|
Escherichia coli (NCBI:txid562) |
See: PubMed |
Escherichia coli metabolite
Any bacterial metabolite produced during a metabolic reaction in
Escherichia coli
.
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
(via anthracycline ) antimicrobial agent
A substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans.
(via anthracycline antibiotic )
|
|
View more via ChEBI Ontology
(1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranoside |
doxorubicin |
ChemIDplus |
doxorubicine |
ChemIDplus |
doxorubicinum |
ChemIDplus |
(1S,3S)-3-glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranoside |
ChEBI |
(8S-cis)-10-((3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione |
ChemIDplus |
14-hydroxydaunomycin |
ChemIDplus |
14-hydroxydaunorubicine |
ChemIDplus |
Adriamycin |
KEGG COMPOUND |
Adriamycin |
KEGG COMPOUND |
Doxorubicin |
KEGG COMPOUND |
DOXORUBICIN |
PDBeChem |
960 |
DrugCentral |
C01661 |
KEGG COMPOUND |
D03899 |
KEGG DRUG |
DB00997 |
DrugBank |
DM2 |
PDBeChem |
LMPK13050001 |
LIPID MAPS |
LSM-4062 |
LINCS |
View more database links |
23214-92-8 |
CAS Registry Number |
KEGG COMPOUND |
23214-92-8 |
CAS Registry Number |
ChemIDplus |
|